Skip to content
Homepage
Author:
Racura Oncology Limited
Posted Date:
June 25, 2026
Racura Oncology Doses First Patient in Phase 1 HARNESS-1 Trial of RC220 in EGFR-Mutant Non-Small Cell Lung Cancer
Racura Oncology Limited
June 25, 2026
